Skip to content

US · UNH · MEDICAL - HEALTHCARE PLANS

UnitedHealth Group Incorporated (UNH) intrinsic value and stock valuation

$339.85as of 2026-11-21 · Mkt cap 374.84B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

UnitedHealth Group Incorporated DCF and intrinsic value

InvestorsCraft values UNH with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from UNH’s statements →

UnitedHealth Group Incorporated Graham Number

Graham Number: $182.52d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Healthcare Plans Eden Prairie, MN 55344 unitedhealthgroup.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$447.6B+11.7% 5y CAGRd
20112025
Net income
$12.1B-4.8% 5y CAGRd
20112025
Free cash flow
$16.1B-4.4% 5y CAGRd
20112025
Total equity
$101.7B+7.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$447.6B$400.3B$371.6B$324.2B$287.6B
Operating income$19B$32.3B$32.4B$28.4B$24B
Net income$12.1B$14.4B$22.4B$20.1B$17.3B
EPSd$13.2M$15.5M$23.9M$21.2M$18.1M
Operating cash flow$19.7B$24.2B$29.1B$26.2B$22.3B
Capital expenditure-$-3.62B-$-3.5B-$-3.39B-$-2.8B-$-2.45B
Free cash flow$16.1B$20.7B$25.7B$23.4B$19.9B
Total assets$309.6B$298.3B$273.7B$245.7B$212.2B
Total debt$78.4B$76.9B$67.4B$57.6B$46B
Net debt$54B$51.6B$42B$34.3B$24.6B
Total equity$101.7B$102.6B$98.9B$86.3B$76.5B
Cash and short-term investments$28.1B$29.1B$29.6B$27.9B$23.9B
Income statement
20252024202320222021
Revenue$447.6B$400.3B$371.6B$324.2B$287.6B
Cost of revenue$364.7B$310.9B$280.7B$244.5B$217.9B
Gross profit$82.9B$89.4B$91B$79.6B$69.7B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$0.00$0.00$0.00$0.00
Other expenses$64B$57.1B$58.6B$51.2B$45.7B
Operating expenses$64B$57.1B$58.6B$51.2B$45.7B
Cost and expenses$428.6B$368B$339.3B$295.7B$263.6B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$4B$3.91B$3.25B$2.09B$1.66B
Depreciation and amortization$4.36B$4.1B$3.97B$3.4B$3.1B
Ebitda$23.1B$28.1B$36.3B$31.8B$27.1B
Operating income$19B$32.3B$32.4B$28.4B$24B
Total other income/expenses, net-$-4.27B-$-12.22B-$-3.25B-$-2.09B-$-1.66B
Income before tax$14.7B$20.1B$29.1B$26.3B$22.3B
Income tax expense$1.89B$4.83B$5.97B$5.7B$4.58B
Net income$12.1B$14.4B$22.4B$20.1B$17.3B
Weighted average shares outstanding$910M$929M$928M$934M$943M
Weighted average diluted shares outstanding$910M$929M$938M$950M$956M
Balance sheet
20252024202320222021
Cash and short-term investments$28.1B$29.1B$29.6B$27.9B$23.9B
Net receivables$52.7B$48.5B$39B$30.5B$28.1B
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$90.6B$85.8B$78.4B$69.1B$61.8B
Property, plant and equipment, net$10.8B$10.6B$11.5B$10.1B$8.97B
Goodwill and intangible assets$131B$130B$118.9B$107.8B$85.8B
Long-term investments$54.3B$52.4B$47.6B$43.7B$43.1B
Total non-current assets$219B$212.5B$195.3B$176.6B$150.4B
Total assets$309.6B$298.3B$273.7B$245.7B$212.2B
Accounts payable$77.4B$68.6B$32B$56.8B$49.1B
Short-term debt$6.07B$4.55B$5.31B$3.11B$3.62B
Deferred revenue$3.41B$3.32B$3.36B$3.08B$2.57B
Total current liabilities$114.9B$103.8B$99.1B$89.2B$78.3B
Long-term debt$72.3B$72.4B$62.1B$54.5B$42.4B
Deferred revenue, non-current$0.00$0.00$3.36B$0.00-$-3.27B
Total non-current liabilities$93B$91.9B$80.4B$70.1B$57.4B
Capital lease obligations$0.00$0.00$3.86B$0.00$0.00
Total liabilities$207.9B$195.7B$174.8B$159.4B$135.7B
Common stock$9M$9M$9M$9M$10M
Retained earnings$95.6B$96B$95.8B$86.2B$77.1B
Accumulated other comprehensive income (loss)-$-2.06B-$-3.39B-$-7.03B-$-8.39B-$-5.38B
Total equity$101.7B$102.6B$98.9B$86.3B$76.5B
Total investments$58B$56.2B$51.8B$48.3B$45.6B
Total debt$78.4B$76.9B$67.4B$57.6B$46B
Net debt$54B$51.6B$42B$34.3B$24.6B
Cash flow statement
20252024202320222021
Net income$12.8B$15.2B$22.4B$20.1B$17.3B
Depreciation and amortization$4.36B$4.1B$3.97B$3.4B$3.1B
Stock-based compensation$971M$1.02B$1.06B$925M$800M
Change in working capital$2.28B-$-808M$1.64B$2.25B$1.52B
Accounts receivable$0.00-$-1.44B-$-3.11B-$-2.52B-$-1B
Inventory$0.00$0.00$1.04B$0.00-$-1.03B
Accounts payable$0.00$2.46B$3.52B$1.96B$3.86B
Net cash provided by operating activities$19.7B$24.2B$29.1B$26.2B$22.3B
Investments in property, plant and equipment-$-3.62B-$-3.5B-$-3.39B-$-2.8B-$-2.45B
Acquisitions, net-$-4.51B-$-13.41B-$-10.14B-$-21.46B-$-4.82B
Net cash used for investing activities-$-8.69B-$-20.53B-$-15.57B-$-28.48B-$-10.37B
Common stock issued$0.00$1.85B$1.35B$1.25B$1.36B
Common stock repurchased-$-5.55B-$-9B-$-8B-$-7B-$-5B
Dividends paid-$-7.92B-$-7.53B-$-6.76B-$-5.99B-$-5.28B
Net cash used for financing activities-$-11.64B-$-3.51B-$-11.53B$4.23B-$-7.46B
Net change in cash$2.81B-$-115M$2.06B$1.99B$4.45B
Cash at end of period$28.1B$25.3B$25.4B$23.4B$21.4B
Operating cash flow$19.7B$24.2B$29.1B$26.2B$22.3B
Capital expenditure-$-3.62B-$-3.5B-$-3.39B-$-2.8B-$-2.45B
Free cash flow$16.1B$20.7B$25.7B$23.4B$19.9B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About UnitedHealth Group Incorporated

        UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

        CEO
        Stephen J. Hemsley
        Employees
        390K
        Beta
        0.63

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of UnitedHealth Group Incorporated (UNH)?

        UnitedHealth Group Incorporated (UNH) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is UNH undervalued?

        UNH trades at a price of $339.85 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.